We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thyroid Lesions Examined by Scanning Acoustic Microscope

By LabMedica International staff writers
Posted on 05 Mar 2014
Print article
Image: The scanning acoustic microscope AMS-50SI system (Photo courtesy of Honda Electronics Co, Ltd).
Image: The scanning acoustic microscope AMS-50SI system (Photo courtesy of Honda Electronics Co, Ltd).
A scanning acoustic microscope (SAM) uses ultrasound to image an object by plotting the speed-of-sound (SOS) through tissues on screen, and because hard tissues result in great SOS, SAM can provide data on the tissue elasticity.

Scanning acoustic microscopy uses ultrasound at 120 MHz with almost the same resolution of approximately 12.5 μm as the low magnification of a light microscope (LM), and it had been found useful in generating useful information on the lung, stomach, and lymph node lesions.

Scientists at Hamamatsu University School of Medicine (Japan) selected and examined formalin-fixed, paraffin-embedded blocks that were flat-sectioned in 10 μm thick sections from patients with inflammatory non-neoplastic and neoplastic thyroid lesions. Specimens were randomly selected from the computer database of pathological sections and typical lesions of thyroid diseases were identified based on hematoxylin and eosin sections.

The formalin-fixed, paraffin sections were scanned with a 120 MHz transducer using the SAM model AMS-50AI (Honda Electronics Co, Ltd; Toyohashi, Japan). SOS through each area was calculated and plotted on the screen to provide histological images, and SOS of each lesion was compared and statistically analyzed.

High-concentrated colloids, red blood cells, and collagen fibers showed pronounced SOS while low-concentrated colloids, parathyroids, lymph follicles, and epithelial tissues including carcinomas demonstrated lower SOS. SAM clearly discriminated structure of thyroid components corresponding to low magnification of light microscopy. Thyroid tumors were classified into three groups by average SOS: the fast group consisted of follicular adenomas/carcinomas and malignant lymphomas; the slow group contained poorly differentiated/undifferentiated carcinomas; and the intermediate group comprised papillary/medullary carcinomas.

The authors concluded that SAM imaging has the following benefits: precise images were acquired in a few minutes without special staining; structural irregularity and desmoplastic reactions, which indicated malignancy, were detected; images reflected tissue elasticity, which was statistically comparable among lesions by SOS; and tumor classification was predictable by SOS because more poorly differentiated carcinomas had a tendency to show lower SOS. The study was published on February 11, 2014, in the journal Pathology and Laboratory Medicine International.

Related Links:

Hamamatsu University School of Medicine 
Honda Electronics Co, Ltd 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.